Related by context. Frequent words. (Click for all words.) 75 liposomal formulation 75 Aliskiren 75 Irinotecan 74 Dasatinib 73 pertuzumab 73 Torisel 72 proteasome inhibitor 72 Panzem R 72 Lenalidomide 72 Factor VIIa 71 Erlotinib 71 metastatic hormone refractory 71 vorinostat 71 Vandetanib 71 R sorafenib tablets 71 Gemzar ® 71 Amrubicin 71 Mipomersen 71 Epratuzumab 71 BAY #-# 71 Nexavar ® 71 Ixempra 71 trastuzumab Herceptin 71 elotuzumab 70 KRN# 70 BMS # 70 GSK# [001] 70 PEG SN# 70 Voreloxin 70 SERMs 70 relapsing multiple sclerosis 70 goserelin 70 Abacavir 70 Carfilzomib 70 mycophenolate mofetil 70 Pirfenidone 70 Natalizumab 70 bevacizumab Avastin 70 Tacrolimus 70 Rebif ® 70 mRCC 70 anticancer compound 70 Bevacizumab 70 Drug Candidate 70 irbesartan 69 Traficet EN 69 Capecitabine 69 Zolinza 69 Trastuzumab 69 Pegasys ® 69 Hycamtin 69 MEK inhibitor 69 angiogenesis inhibitor 69 phase IIb clinical 69 gastrointestinal stromal tumors GIST 69 Tesetaxel 69 Pegintron 69 ixabepilone 69 DOXIL 69 tigecycline 69 Sorafenib 69 administered subcutaneously 69 TLR9 agonist 69 Adalimumab 69 forodesine 69 Cetrorelix 69 Laquinimod 68 tocilizumab 68 ZD# [001] 68 orally bioavailable 68 TYKERB 68 diabetic neuropathic pain 68 interferon beta 1b 68 mTOR inhibitor 68 Telmisartan 68 ACZ# 68 Boceprevir 68 eltrombopag 68 SCH # 68 SAR# [004] 68 multiple myeloma MM 68 immunomodulators 68 tyrosine kinase inhibitor 68 Bortezomib 68 Alemtuzumab 68 Analgesic 68 Pivotal Phase III 68 Sym# 68 IRESSA 68 Taxotere ® 68 fluvastatin 68 Pulmonary Arterial Hypertension 68 Avastin bevacizumab 68 bendamustine 68 APTIVUS 68 multi kinase inhibitor 68 LY# [003] 68 secondary hyperparathyroidism 68 metastatic renal cell carcinoma 68 luteinizing hormone releasing 68 PARP inhibitor